![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 20, 2014 1:31:34 PM
F.D.A. granting the O.D.D. for MANF for Retinitis Pigmentosa.
I expect it will happen and AMBS will ink a development deal that will yield a substantial up-front cash payment and put "MANF" on the bio-tech map.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,200 followers.
p.s. If someone wants to sell shares for under eight cent there will be buyers. Possibly Gerald will be one of them as under eight cents is better than .086.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM